COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Fountain Asset Corp. Announces Its Financial Results for the Quarter and Year Ended December 31, 2025
Fountain Asset Corp. announces financial results for Q4/25 and Fiscal 2025 showing NAV increase. Company maintains low operating expenses and strategic investments in technology and mining sectors -
COMMUNIQUÉ DE PRESSE
LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic Molecules
LIR Life Sciences Corp. announces the launch of a controlled ex vivo porcine skin study to evaluate protamine's impact on transdermal movement of macromolecular therapeutics. The study aims to advance needle-free delivery options for larger molecules -
COMMUNIQUÉ DE PRESSE
Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program
Onco-Innovations successfully scales up key intermediates A83 and B4, advancing its CMC program for nanoparticle-based PNKP inhibitor drug ONC010. Collaborates with Dalton Pharma Services for process optimization and future GMP manufacturing -
-
-
-
